Article citationsMore>>

Swedberg, K., Komajda, M., Bohm, M., Borer, J.S., Ford, I., Dubost-Brama, A., et al. (2010) Ivabradine and Outcomes in Chronic Heart Failure (SHIFT): A Randomised Placebo-Controlled Study. The Lancet, 376, 875-885.
https://doi.org/10.1016/S0140-6736(10)61198-1

has been cited by the following article:

• TITLE: Ivabradine—The Final Crusader for Postoperative Junctional Ectopic Tachycardia, a Case Report with Literature Review

  AUTHORS: Manoj Kumar Sahu, Harsha Vardhan Niraghatam, Nikhil Bansal, Sarvesh Pal Singh, Palleti Rajashekar, Shiv Kumar Choudhary

  KEYWORDS: Tetralogy of Fallot, Junctional Ectopic Tachycardia, Ivabradine

  JOURNAL NAME: World Journal of Cardiovascular Surgery, Vol.9 No.8, August 22, 2019

  ABSTRACT: Background: Junctional ectopic tachycardia (JET) is one troublesome supraventricular arrhythmia in postoperative pediatric cardiac surgical patients. Unless treated timely and effectively it may lead to morbidity and even mortality. Aim: To understand the role of Ivabradine in the treatment of JET in postoperative pediatric cardiac surgical patients. Case: We present a postoperative case of complete repair of Tetralogy of Fallot who was in normal sinus rhythm in the preoperative period and developed JET 4 hours later in postoperative period which was persistent despite measures to optimize the internal milieu of the body and conventional antiarrhythmics, that was successfully treated with Ivabradine at a dose of 0.05 mg/kg/12 hourly. Conclusion: Ivabradine can be used to successfully treat postoperative JET in cases ofrefractory to other antiarrhythmic drugs like Digoxin and Amiodarone.